Abstract
Alzheimer disease (AD) is one of the most common degenerative illnesses of the elderly worldwide. It is a progressive neurological condition that impairs cognitive memory. As a result, Alzheimer's sufferers struggle to recall daily activities, recollect family members, and solve logical problems. Medication which reduces the creation of proteins, block data communication between brain neurons and it can also delay the course of Alzheimer's disease. Mild Cognitive Impairment (MCI) seems to be a common disorder that does not usually progress to Alzheimer's. It is difficult to find patients with modest cognitive decline who may acquire Alzheimer's. As a result, creating deep learning-based disease detection techniques to assist clinicians in detecting prospective Alzheimer's patients is crucial. The performance comparison of the Imaging, Electronic Health Record (EHR), and Single nucleotide polymorphisms (SNP) datasets is evaluated using the metrics Accuracy, Sensitivity, Specificity, and Multi Area. Different mistakes are added under the curves for gradient calculation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
